SCHEMBL6170720

SCHEMBL6170720

CC(=O)Nc1ccc(C(=O)NS(=O)(=O)c2ccccc2)cc1NCc1ccc(C(F)(F)F)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.50
BCL2L1 Q07817 1/20 0.49
MCL1 Q07820 1/20 0.49
PTGER4 P35408 1/20 0.46
EPHX2 P34913 1/20 0.44
POLB P06746 2/20 0.44
RECQL P46063 1/20 0.44
MAPT P10636 1/20 0.44
PPARG P37231 2/20 0.43
HDAC8 Q9BY41 4/20 0.43
HDAC1 Q13547 2/20 0.43
HDAC6 Q9UBN7 2/20 0.43
HSD11B1 P28845 1/20 0.42
LMNA P02545 1/20 0.42
RAB9A P51151 1/20 0.42
KAT6A Q92794 1/20 0.42
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
KMT2A Q03164 1/20 0.41
MAPK14 Q16539 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6169259 0.90 HDAC8 (0.52) PTPN1MAPTHDAC8HDAC1HDAC6
SCHEMBL6170460 0.84 FLT1 (0.47) BCL2L1MCL1POLBMAPTHSD11B1
SCHEMBL6171685 0.83 BCL2L1 (0.54) BCL2L1MCL1PTGER4POLBRAB9A
SCHEMBL6172330 0.81 HDAC8 (0.54) BCL2L1MCL1PTGER4HDAC8HDAC1
SCHEMBL6169006 0.79 PTPN1 (0.45) PTPN1POLBMAPTHDAC8LMNA
SCHEMBL6169334 0.79 IDO1 (0.42) PTPN1BCL2L1MCL1HDAC8HDAC1
SCHEMBL19248164 0.77 PTPN1 (0.64) PTPN1BCL2L1MCL1PTGER4POLB
SCHEMBL6172767 0.77 HDAC8 (0.52) BCL2L1MCL1PTGER4MAPTHDAC8
SCHEMBL6170355 0.76 ALDH1A1 (0.48) BCL2L1MCL1POLBMAPTMEN1
SCHEMBL6168605 0.75 HDAC1 (0.50) BCL2L1MCL1PTGER4HDAC8HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882718-B1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO (JP) 2005-08-31 EP disclosed
US-6352985-B1 CARDIOVASCULAR DISORDERS OR GASTROINTESTINAL DISORDERS, DIABETES (TYPE II DIABETES), DIABETIC COMPLICATIONS METHOD FOR LOWERING THE BLOOD SUGAR LEVEL OF A PATIENT, FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-03-05 US disclosed
US-6348032-B1 POTENT COMPOUNDS THAT INDUCE APOPTOSIS IN NEOPLASTIC CELLS (BUT NOT SUBSTANTIALLY IN NORMAL CELLS), WITHOUT SUBSTANTIALLY INHIBITING PGE-2. CELL PATHWAYS, INC. 2002-02-19 US disclosed
US-6166219-A Benzimidazole derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-12-26 US disclosed
EP-0882718-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-09 EP disclosed